Equifax SEC filings document the company’s operating results, capital structure, governance, and material corporate agreements. Recent Form 8-K reports include quarterly financial-results releases and amendments to the company’s unsecured revolving credit facility involving Equifax and subsidiary borrowers.
Regulatory records also identify Equifax common stock listed on the New York Stock Exchange under EFX. Proxy materials cover annual meeting matters, board and shareholder voting topics, executive compensation, and company discussion of data, cloud technology, security, and EFX.AI within its public-company governance framework.
Equifax director Mark L. Feidler received an equity grant valued at a set share price as part of his annual board compensation. He was awarded 1,253 shares at $175.62 per share under the company’s long-term incentive plan, structured as restricted stock units that vest 100% on May 7, 2027.
Following this grant, Feidler directly holds 25,077 shares. The position includes accrued dividend equivalent units, which reflect dividends reinvested into corresponding restricted stock units through the company’s last dividend payment date. This filing reflects a compensation-related acquisition rather than an open-market stock purchase.
Equifax executive Chad M. Borton reported selling common stock and covering taxes through share withholding. On May 7, 2026, he completed an open-market sale of 2,455 shares of Equifax common stock at $173.89 per share. On May 6, 2026, 1,934 shares were disposed of as a tax-withholding transaction at $173.20 per share, rather than an open-market sale. After these transactions, Borton directly held 29,518 shares of Equifax common stock. According to a footnote, the sales were executed under a Rule 10b5-1 trading plan adopted by the reporting person, indicating they were pre-scheduled rather than opportunistic market timing.
The filing is a Rule 144 notice for EFX reporting 2,455 shares of Common stock tied to a Restricted Stock Vesting event dated 05/06/2026. The broker listed is Fidelity Brokerage Services LLC. The filing also records a prior sale of 2,535 shares on 02/12/2026 for $485,452.50.
Equifax Inc. executive John W. Gamble Jr., EVP, CFO & COO, sold 3,500 shares of common stock in an open-market transaction. The sale occurred at a price of $176.54 per share, and he now directly holds 73,464 shares of Equifax common stock.
The transaction was carried out under a Rule 10b5-1 trading plan that he adopted on November 21, 2025, indicating the sale was pre-arranged. His holdings also include accrued dividend equivalent units tied to restricted stock units through the company’s last dividend payment date.
EFX notice of proposed sale under Rule 144 reporting restricted stock vesting events and a recent disposition. The filing lists vested shares from compensation awards dated 02/11/2025, 05/21/2017, and 02/12/2024, and reports a sale of 4,500 shares on 02/23/2026.
The filing names John Gamble Jr. and lists a broker-dealer Fidelity Brokerage Services LLC with an address in Smithfield, RI.
Equifax Inc ownership filing: Vanguard Capital Management reports beneficial ownership of 9,020,869 shares of Common Stock, representing 7.47% of the class as of 03/31/2026. The filing states Vanguard has sole dispositive power over 9,020,869 shares and sole voting power over 1,195,764 shares. The filing is submitted on behalf of Vanguard Capital Management and affiliated Vanguard investment entities and is signed on 04/29/2026.
Equifax Inc. CEO Mark W. Begor reported a combination of stock option exercises and share sales. On April 24, 2026, he exercised stock options to acquire 37,791 shares of Equifax common stock at $112.46 per share, then sold 37,791 shares in multiple open-market transactions at weighted average prices between about $170.98 and $174.78. The sales were carried out under a Rule 10b5-1 trading plan adopted on October 28, 2025, indicating they were pre-scheduled. Following these transactions, Begor directly holds 307,804 shares of Equifax common stock and has additional indirect holdings through several two-year 2025 grantor retained annuity trusts with 12,333, 38,332, 21,284 and 10,500 shares, respectively.
Equifax Inc. amended its main revolving credit agreement to increase available liquidity and extend maturities. The unsecured revolving credit facility commitments rose from $1.5 billion to $2 billion, and swingline loan capacity increased from $150 million to $200 million.
The amendment also removes a 10 basis point credit spread adjustment on Term SOFR borrowings. The termination date for $1.9 billion of the facility is extended by one year from August 25, 2028 to August 25, 2029, while $100 million still terminates on August 25, 2028. All other terms of the credit agreement remain in effect.
Equifax Inc. reported a Form 144 notice for the proposed sale of 37,791 shares of Common Stock by an affiliate on 04/24/2026. The shares were associated with an option granted 05/04/2018 and the transaction is described as a cash sale on the NYSE.